Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignanciesG D Long, M D Amylon, K E Stockerl-Goldstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 1996
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host diseaseN J Chao, P M Parker, J C Niland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosingMichael B Maris, Brenda M Sandmaier, Barry E Storer, et al.
Anais Da Academia Brasileira De Ciencias|March 7, 2024
Bone-marrow mononuclear cells and acellular human amniotic membrane improve global cardiac function without inhibition of the NLRP3 Inflammasome in a rat model of heart failureAline L Takejima, Paulo André B Machado-Júnior, Gustavo G Blume, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplantLyle C Feinstein, Brenda M Sandmaier, David G Maloney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioningMohamed L Sorror, Barry E Storer, Brenda M Sandmaier, et al.
Leukemia|December 22, 1999
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remissionD S Snyder, A P Nademanee, M R O'Donnell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2000
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancerR S Negrin, K Atkinson, T Leemhuis, et al.
Blood|November 14, 1997
Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk groupA Nademanee, A Molina, M R O'Donnell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantationRichard A Nash, Laura Johnston, Pablo Parker, et al.
Pageof 20